Sep 17, 2026FDA approves finerenone for chronic kidney disease in type 1 diabetesThe FDA approved finerenone (Kerendia) for treating chronic kidney disease associated with type 1 diabetes, marking the first new drug approval for this indication in decades.Sep 17, 2026·2 sources00
May 30, 2026Mineralys Therapeutics' Experimental Drug Significantly Reduces Blood Pressure in Chronic Kidney Disease PatientsMineralys Therapeutics presented new data at a major European medical conference showing their experimental pill significantly reduced blood pressure in patients with chronic kidney disease.May 30, 2026·1 source00
